| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f12ce542280aee0a40a1ab08a482e026 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
2020-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ebda1ed8a988c31df6473222a37e167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59fd2c0e72f66baeeb88fbf0e68f08ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_371f0818a3845e2cafd2fa0a42be5007 |
| publicationDate |
2022-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022144840-A1 |
| titleOfInvention |
Heterocyclic compounds and their use in the treatment of amyloid-related diseases |
| abstract |
A compound of Formula (I) or a pharmaceutically acceptable salt thereof is described, wherein the substituents are as defined herein. Pharmaceutical compositions comprising the same and method of using the same are also described. |
| priorityDate |
2019-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |